Detalhe da pesquisa
1.
Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma.
Br J Cancer
; 127(12): 2198-2206, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253523
2.
Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study.
Br J Cancer
; 125(9): 1261-1269, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34493820
3.
Prognostic implications of surgical specimen quality on the oncological outcomes of open and laparoscopic surgery in mid and low rectal cancer.
Langenbecks Arch Surg
; 406(8): 2759-2767, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716825
4.
AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation.
Int J Mol Sci
; 22(23)2021 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884955
5.
Preparation and Evaluation of Mebendazole Microemulsion for Intranasal Delivery: an Alternative Approach for Glioblastoma Treatment.
AAPS PharmSciTech
; 21(7): 264, 2020 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32980937
6.
Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpression.
Mod Pathol
; 32(2): 306-313, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30206410
7.
Improving tumour budding evaluation in colon cancer by extending the assessment area in colectomy specimens.
Histopathology
; 75(4): 517-525, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31081121
8.
Preclinical evidences of safety of a new synthetic adjuvant to formulate with the influenza human vaccine: absence of subchronic toxicity and mutagenicity.
Immunopharmacol Immunotoxicol
; 41(1): 140-149, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30714433
9.
Personalised Treatment in Gastric Cancer: Myth or Reality?
Curr Oncol Rep
; 18(7): 41, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27215435
10.
ctDNA whole exome sequencing in pancreatic ductal adenocarcinoma unveils organ-dependent metastatic mechanisms and identifies actionable alterations in fast progressing patients.
Transl Res
; 271: 105-115, 2024 May 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782356
11.
"Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction".
J Exp Clin Cancer Res
; 42(1): 8, 2023 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36604765
12.
Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Clin Cancer Res
; 28(3): 507-517, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34625408
13.
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review.
Cancers (Basel)
; 13(5)2021 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33673558
14.
Toxicity Evaluation of a Novel Rapamycin Liposomal Formulation After Subconjunctival and Intravitreal Injection.
J Ocul Pharmacol Ther
; 37(5): 261-276, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691483
15.
How we treat metastatic colorectal cancer.
ESMO Open
; 4(Suppl 2): e000813, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32817137
16.
Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress.
J Clin Med
; 9(9)2020 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971757
17.
Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
Cancers (Basel)
; 12(12)2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33287114
18.
Personalized Medicine: Recent Progress in Cancer Therapy.
Cancers (Basel)
; 12(4)2020 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325878
19.
Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre.
ESMO Open
; 5(6): e000929, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33229503
20.
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer.
ESMO Open
; 5(5): e000847, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32967918